{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:35:57Z","timestamp":1759332957421},"reference-count":146,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":3144,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Clin Exp Hematol"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p>In addition to the extensive work that has been conducted in order to understand better the biological features of the leukemic population in B\u2010cell chronic lymphocytic leukemia (CLL), over the years considerable interest has been directed towards other related studies that may have important implications for the accumulation of the leukemic clone and for the immunoparesis typical of this disease. In the present review article, we discuss some of these areas of investigation and, in particular, we focus on: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b1\">(1)<\/jats:ext-link> the multiple abnormalities recorded within the T and cytotoxic compartment of patients with CLL; \n\t\t\t\t\t<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b2\">(2)<\/jats:ext-link> cytokine loops occurring in this disease, with particular emphasis on the cytokines that appear to play a more critical role; and \n\t\t\t\t\t<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b3\">(3)<\/jats:ext-link> the cell\u2010to\u2010cell cross talk that may be actively operational in CLL. These findings will be discussed in relation with the possible implications that each of them have in the expansion and clinical behavior of a disease that is increasingly proving its heterogeneity.<\/jats:p>","DOI":"10.1046\/j.1468-0734.2000.00004.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T19:08:38Z","timestamp":1047496118000},"page":"73-98","source":"Crossref","is-referenced-by-count":7,"title":["Accessory Cells, Cytokine Loops and Cell\u2010to\u2010Cell Interactions in Chronic Lymphocytic Leukemia"],"prefix":"10.1111","volume":"4","author":[{"given":"Enrica","family":"Orsini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Foa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_10_2_2","first-page":"147","volume-title":"Chronic Lymphocytic Leukemia","author":"Foa R.","year":"1993"},{"key":"e_1_2_10_3_2","first-page":"27","article-title":"Impairments in immune cell function in B cell chronic lymphocytic leukemia.","volume":"25","author":"Bartik MM","year":"1998","journal-title":"Semin Oncol"},{"key":"e_1_2_10_4_2","unstructured":"FoaR&GuariniA.Biology of Chronic Lymphocytic Leukemia.Educational Book. American Society of Clinical Oncology pp.178183 1999."},{"key":"e_1_2_10_5_2","first-page":"3","article-title":"Chronic lymphocytic leukemia: Clinical studies based on 189 cases followed for a long time.","volume":"18","author":"Hansen MM.","year":"1973","journal-title":"Scan J Haematol"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510193331606"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90944-1"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<483::AID-CNCR2820440217>3.0.CO;2-Z"},{"key":"e_1_2_10_9_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V54.2.540.540","article-title":"T\u2010cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribution and in vitro maturation.","volume":"54","author":"Kay NE","year":"1979","journal-title":"Blood"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1980.tb02366.x"},{"key":"e_1_2_10_11_2","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.129.5.2305","article-title":"Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia. An analysis by monoclonal antibodies.","volume":"129","author":"Platsoucas CD","year":"1982","journal-title":"J Immunol"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(83)90133-2"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(90)90044-A"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509049770"},{"key":"e_1_2_10_15_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V74.2.786.786","article-title":"T\u2010cell activation and subset patterns are altered in B\u2010CLL and correlate with the stage of the disease.","volume":"74","author":"Totterman TH","year":"1989","journal-title":"Blood"},{"key":"e_1_2_10_16_2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1182\/blood.V78.6.1569.1569","article-title":"Decreased CD45RA T cells in B\u2010cell chronic lymphatic leukemia patients: Correlation with disease stage.","volume":"78","author":"Peller S","year":"1991","journal-title":"Blood"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198701083160202"},{"key":"e_1_2_10_18_2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.122.3.1087","article-title":"T cell helper defect in patients with chronic lymphocytic leukemia.","volume":"122","author":"Chiorazzi N","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1983.00277.x"},{"key":"e_1_2_10_20_2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V71.6.1551.1551","article-title":"Defective helper function of purified T4 dells and excessive suppressor activity of purified T8 cells in patients with B\u2010cell chronic lymphocytic leukemia. T4 suppressor effector cells are present in certain patients.","volume":"71","author":"Kunicka JE","year":"1988","journal-title":"Blood"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800301)45:5<893::AID-CNCR2820450511>3.0.CO;2-Q"},{"key":"e_1_2_10_22_2","first-page":"1563","article-title":"Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti\u2010CD3, and phorbol myristate acetate mitogenic signals.","volume":"21","author":"Prieto A","year":"1993","journal-title":"Exp Hematol"},{"key":"e_1_2_10_23_2","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V83.8.2198.2198","article-title":"Expansion of T cells expressing low CD4 or CD8 levels in B\u2010cell chronic lymphocytic leukemia: Correlation with disease status and neoplastic phenotype.","volume":"83","author":"Dianzani U","year":"1994","journal-title":"Blood"},{"key":"e_1_2_10_24_2","first-page":"494","article-title":"Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.","volume":"10","author":"Rossi E","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_10_25_2","first-page":"5613","article-title":"Loss of T\u2010cell receptor \u03be chain and p56lck in T\u2010cells infiltrating human renal cell carcinoma.","volume":"53","author":"Finke JH","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_10_26_2","first-page":"5610","article-title":"Decreased expression of the signal\u2010transducing zeta chains in tumor\u2010infiltrating T\u2010cells and NK cells of patients with colorectal carcinoma.","volume":"53","author":"Nakagomi H","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.5.1753"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.6.1957"},{"key":"e_1_2_10_29_2","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.4049\/jimmunol.153.9.4281","article-title":"T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.","volume":"153","author":"Farace F","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_10_30_2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4049\/jimmunol.158.3.1482","article-title":"Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.","volume":"158","author":"Serrano D","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_10_31_2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V94.3.1063.415a17_1063_1069","article-title":"Oligoclonal TCRBV gene usage in B\u2010cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T\u2010cell subset.","volume":"94","author":"Rezvany MR","year":"1999","journal-title":"Blood"},{"key":"e_1_2_10_32_2","first-page":"5968","article-title":"Autologous T cells control B\u2010chronic lymphocytic leukemia tumor progression in human mouse radiation chimera.","volume":"59","author":"Shimoni A","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400598"},{"key":"e_1_2_10_34_2","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V93.6.1992.406k23_1992_2002","article-title":"CD40\u2010activated B\u2010cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.","volume":"93","author":"Buhmann R","year":"1999","journal-title":"Blood"},{"key":"e_1_2_10_35_2","unstructured":"CielinskaSM RassentiLZ KippsTJ.CD154 (CD40\u2010ligand) gene immunization of CLL patients leads to amnestic T cell responses.Proceedings of the VIII International Workshop on CLL Paris 29\u201331 October 1999 p.67 1999."},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909050958"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb02911.x"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb03998.x"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-2712(18)30704-2"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(90)90044-S"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00345.x"},{"key":"e_1_2_10_42_2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4049\/jimmunol.125.3.1216","article-title":"Defective spontaneous and antibody\u2010dependent cytotoxicity mediated by E\u2010rosette\u2010positive and E\u2010rosette\u2010negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.","volume":"125","author":"Platsoucas CD","year":"1980","journal-title":"J Immunol"},{"key":"e_1_2_10_43_2","first-page":"547","article-title":"Recombinant alpha\u20102b\u2010interferon may restore natural\u2010killer activity in patients with B\u2010chronic lymphocytic leukemia.","volume":"6","author":"Villamor N","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_10_44_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V63.2.305.305","article-title":"Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells.","volume":"63","author":"Kay NE","year":"1984","journal-title":"Blood"},{"key":"e_1_2_10_45_2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1182\/blood.V76.7.1349.1349","article-title":"Lymphokine\u2010activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to autologous and allogeneic LAK effectors.","volume":"76","author":"Foa R","year":"1990","journal-title":"Blood"},{"key":"e_1_2_10_46_2","first-page":"1016","article-title":"Evidence that large granular lymphocytes from B\u2010CLL patients with hypogammaglobulinemia down\u2010regulate B\u2010cell immunoglobulin synthesis.","volume":"73","author":"Kay NE","year":"1989","journal-title":"Blood"},{"key":"e_1_2_10_47_2","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.157.5.1919","article-title":"Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine\u2010activated killer cells.","volume":"157","author":"Lee RK","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(97)01080-3"},{"key":"e_1_2_10_49_2","first-page":"1425","article-title":"The IL\u20102 receptor complex: expression and function on normal and leukemic B cells.","volume":"9","author":"De Totero D","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_10_50_2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V66.3.614.614","article-title":"Interleukin 2 (IL2) and interferon\u2010\u03b3 production by T lymphocytes from patients with B\u2010chronic lymphocytic leukemia: evidence that normally released IL2 is absorbed by the neoplastic B cell population.","volume":"66","author":"Foa R","year":"1985","journal-title":"Blood"},{"key":"e_1_2_10_51_2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood.V70.2.396.396","article-title":"High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia.","volume":"70","author":"Semenzato G","year":"1987","journal-title":"Blood"},{"key":"e_1_2_10_52_2","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.4049\/jimmunol.137.12.3841","article-title":"The released interleukin 2 receptor binds interleukin 2 efficiently.","volume":"137","author":"Rubin LA","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_10_53_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.V67.2.279.279","article-title":"Defective interleukin\u20102 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety.","volume":"67","author":"Ayanlar\u2010Batuman O","year":"1986","journal-title":"Blood"},{"key":"e_1_2_10_54_2","first-page":"399","article-title":"Immunoregulatory T\u2010cell defects in B\u2010cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of a decreased availability of interleukin 2 (IL2).","volume":"12","author":"Foa R","year":"1987","journal-title":"Blood Cells"},{"key":"e_1_2_10_55_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood.V67.1.228.228","article-title":"Lymphokine induction of NK\u2010like cytotoxicity in T cells from B\u2010CLL.","volume":"67","author":"Alvarez de Mon M","year":"1986","journal-title":"Blood"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.161.5.1225"},{"key":"e_1_2_10_57_2","first-page":"339","article-title":"Autocrine and paracrine models of cytokine production and utilization in B\u2010cell chronic lymphocytic leukaemia.","volume":"30","author":"Foa R","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb07615.x"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91782-5"},{"key":"e_1_2_10_60_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood.V76.2.393.bloodjournal762393","article-title":"Production of tumor necrosis factor\u2010alpha by B\u2010cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.","volume":"76","author":"Foa R","year":"1990","journal-title":"Blood"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90169-4"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02785875"},{"key":"e_1_2_10_63_2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood.V73.5.1242.1242","article-title":"Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.","volume":"73","author":"Digel W","year":"1989","journal-title":"Blood"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(89)90004-0"},{"key":"e_1_2_10_65_2","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1182\/blood.V84.12.4249.bloodjournal84124249","article-title":"Expression and regulation of tumor necrosis factor, interleukin\u20102, and hematopoietic growth factor receptors in B\u2010cell chronic lymphocytic leukemia.","volume":"84","author":"Trentin L","year":"1994","journal-title":"Blood"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830430202"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900110104"},{"key":"e_1_2_10_68_2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V76.8.1607.1607","article-title":"Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo.","volume":"76","author":"Digel W","year":"1990","journal-title":"Blood"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409051650"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709039020"},{"key":"e_1_2_10_71_2","unstructured":"CapalboS LapietraA MeleG et al.Serum levels of TNF\u2010\u03b1 and IL\u20106 in B\u2010CLL patients with anemia.Proceedings of the VIII International Workshop on CLL Paris 29\u201331 October 1999.p.45 1999."},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114265"},{"key":"e_1_2_10_73_2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4049\/jimmunol.144.4.1323","article-title":"Leukocyte specificity and binding of human neutrophil attractant\/activation protein\u20101.","volume":"144","author":"Leonard EJ","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(89)91043-0"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)80095-6"},{"key":"e_1_2_10_76_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V84.1.220.220","article-title":"Cytokine gene expression in B\u2010cell chronic lymphocytic leukemia: Evidence of constitutive interleukin\u20108 (IL\u20108) mRNA expression and secretion of biologically active IL\u20108 protein.","volume":"84","author":"Francia di Celle P","year":"1994","journal-title":"Blood"},{"key":"e_1_2_10_77_2","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V87.10.4382.bloodjournal87104382","article-title":"Interleukin\u20108 induces the accumulation of B\u2010cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.","volume":"87","author":"Francia di Celle P","year":"1996","journal-title":"Blood"},{"key":"e_1_2_10_78_2","first-page":"208","article-title":"Clinico\u2010biological implications of increased serum levels of interleukin\u20108 in B\u2010cell chronic lymphocytic leukemia.","volume":"84","author":"Molica S","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.3.914"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.1.85"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830200903"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1993.1186"},{"key":"e_1_2_10_83_2","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V80.12.3173.3173","article-title":"Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B\u2010cell tropic factors.","volume":"80","author":"Fluckiger AC","year":"1992","journal-title":"Blood"},{"key":"e_1_2_10_84_2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V80.5.1299.1299","article-title":"Interleukin\u20104 inhibits both paracrine and autocrine tumor necrosis factor\u2010alpha\u2010induced proliferation of B chronic lymphocytic leukemia cells.","volume":"80","author":"Van Kooten C","year":"1992","journal-title":"Blood"},{"key":"e_1_2_10_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(94)90009-4"},{"key":"e_1_2_10_86_2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood.V71.5.1461.1461","article-title":"Analysis of signal transduction in B chronic lymphocytic leukemia cells.","volume":"71","author":"Drexler HG","year":"1988","journal-title":"Blood"},{"key":"e_1_2_10_87_2","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.4049\/jimmunol.144.6.2351","article-title":"Altered signal transduction secondary to surface IgM cross\u2010linking on B\u2010chronic lymphocytic leukemia cells. Differential activation of the phosphatidylinositol\u2010specific phospholipase C.","volume":"144","author":"Hivroz C","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.5.1319"},{"key":"e_1_2_10_89_2","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood.V84.7.2297.2297","article-title":"Interleukin\u20105 (IL\u20105) increases spontaneous apoptosis of B\u2010cell chronic lymphocytic leukemia cells in vitro independently of bcl\u20102 expression and is inhibited by IL\u20104.","volume":"84","author":"Mainou\u2010Fowler T","year":"1994","journal-title":"Blood"},{"key":"e_1_2_10_90_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2107.x"},{"key":"e_1_2_10_91_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01219.x"},{"key":"e_1_2_10_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(96)00053-7"},{"key":"e_1_2_10_93_2","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood.V88.6.2172.bloodjournal8862172","article-title":"Theophylline synergizes with chlorambucil in inducing apoptosis of B\u2010chronic lymphocytic leukemia cells.","volume":"88","author":"Mentz F","year":"1996","journal-title":"Blood"},{"key":"e_1_2_10_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2113028.x"},{"key":"e_1_2_10_95_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.4.1172"},{"key":"e_1_2_10_96_2","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1016\/S0167-5699(05)80015-5","article-title":"Role of IL\u201010 in cross\u2010regulation of Th1 and Th2 responses.","volume":"12","author":"Mosmann TR","year":"1991","journal-title":"Immunol Tod"},{"key":"e_1_2_10_97_2","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL\u201010 acts on the antigen\u2010presenting cell to inhibit cytokine production by Th1 cells.","volume":"146","author":"Fiorentino DF","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_10_98_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.00358.x"},{"key":"e_1_2_10_99_2","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1182\/blood.V89.11.4146","article-title":"Characterization of interleukin\u201010 receptor expression on B\u2010cell chronic lymphocytic leukemia cells.","volume":"89","author":"Jurlander J","year":"1997","journal-title":"Blood"},{"key":"e_1_2_10_100_2","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1182\/blood.V86.11.4382b.bloodjournal86114382b","article-title":"Serum levels of interleukin\u201010 in B\u2010cell chronic lymphocytic leukemia.","volume":"86","author":"Knauf WU","year":"1995","journal-title":"Blood"},{"key":"e_1_2_10_101_2","first-page":"211","article-title":"IL\u201010 serum levels in B\u2010cell chronic lymphocytic leukaemia.","volume":"94","author":"Egle A","year":"1996","journal-title":"Br J Haematol"},{"key":"e_1_2_10_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(99)00066-1"},{"key":"e_1_2_10_103_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116977"},{"key":"e_1_2_10_104_2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V85.4.1063.bloodjournal8541063","article-title":"Lymphomagenesis in the SCID\u2010hu mouse involves abundant production of human interleukin\u201010.","volume":"85","author":"Baiocchi RA","year":"1995","journal-title":"Blood"},{"key":"e_1_2_10_105_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.1.91"},{"key":"e_1_2_10_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05017.x"},{"key":"e_1_2_10_107_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.1.213"},{"key":"e_1_2_10_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19991015)38:5<224::AID-CYTO4>3.0.CO;2-0"},{"key":"e_1_2_10_109_2","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.4049\/jimmunol.163.10.5599","article-title":"Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL\u201010.","volume":"163","author":"MacDonald KP","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_10_110_2","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.4049\/jimmunol.163.9.5020","article-title":"T cell\u2010derived IL\u201010 promotes lung cancer growth by suppressing both T cell and APC function.","volume":"163","author":"Sharma S","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_10_111_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2407"},{"key":"e_1_2_10_112_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.9.1.7821763"},{"key":"e_1_2_10_113_2","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.4049\/jimmunol.158.5.2090","article-title":"Reciprocal regulation of CD30 expression on CD4+ T cells by IL\u20104 and IFN\u2010gamma.","volume":"158","author":"Nakamura T","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_10_114_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1997.1228"},{"key":"e_1_2_10_115_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V95.1.231","article-title":"Human Tc1 and Tc2\/Tc0, CD8 T\u2010cell clones display distinct cell surface and functional phenotypes.","volume":"95","author":"Vukmanovic\u2010Stejic M","year":"2000","journal-title":"Blood"},{"key":"e_1_2_10_116_2","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood.V89.6.2048","article-title":"CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.","volume":"89","author":"Gattei V","year":"1997","journal-title":"Blood"},{"key":"e_1_2_10_117_2","first-page":"4940","article-title":"B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.","volume":"57","author":"Trentin L","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_10_118_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03521.x"},{"key":"e_1_2_10_119_2","doi-asserted-by":"publisher","DOI":"10.1038\/342929a0"},{"key":"e_1_2_10_120_2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.4049\/jimmunol.152.5.2163","article-title":"T\u2010BAM\/CD40\u2010L on helper T lymphocytes augments lymphokine\u2010induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.","volume":"152","author":"Lederman S","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_10_121_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.1.113"},{"key":"e_1_2_10_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/374163a0"},{"key":"e_1_2_10_123_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.138.3.788","article-title":"Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell\u2010specific antigen BP50 (CDW40).","volume":"138","author":"Ledbetter JA","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_10_124_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.148.6.1570"},{"key":"e_1_2_10_125_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.4.1091"},{"key":"e_1_2_10_126_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7679801"},{"key":"e_1_2_10_127_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0997-984"},{"key":"e_1_2_10_128_2","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V91.8.2689.2689_2689_2697","article-title":"Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T\u2010cell type costimulatory capacity.","volume":"91","author":"Schattner EJ","year":"1998","journal-title":"Blood"},{"key":"e_1_2_10_129_2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","article-title":"Triggering of CD40 antigen inhibits fludarabine\u2010induced apoptosis in B chronic lymphocytic leukemia cells.","volume":"92","author":"Romano MF","year":"1998","journal-title":"Blood"},{"key":"e_1_2_10_130_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00522.x"},{"key":"e_1_2_10_131_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1472"},{"key":"e_1_2_10_132_2","unstructured":"KippsTJ WierdaWG WoodsSJ et al.Gene therapy for CLL.Proceedings of the VIII International Workshop in CLL Paris. 29\u201331 October 1999.p.24 1999."},{"key":"e_1_2_10_133_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.5.1747"},{"key":"e_1_2_10_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90326-L"},{"key":"e_1_2_10_135_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7539157"},{"key":"e_1_2_10_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02293-3"},{"key":"e_1_2_10_137_2","first-page":"1227","article-title":"Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.","volume":"9","author":"Panayiotidis P","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_10_138_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4963301.x"},{"key":"e_1_2_10_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00158-1"},{"key":"e_1_2_10_140_2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1182\/blood.V85.6.1562.bloodjournal8561562","article-title":"Identification of soluble APO\u20101 in supernatants of human B\u2010 and T\u2010cell lines and increased serum levels in B\u2010 and T\u2010cell leukemias.","volume":"85","author":"Knipping E","year":"1995","journal-title":"Blood"},{"key":"e_1_2_10_141_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230320"},{"key":"e_1_2_10_142_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.422688.x"},{"key":"e_1_2_10_143_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270510"},{"key":"e_1_2_10_144_2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.V79.11.2981.2981","article-title":"Growth\u2010 and differentiation\u2010associated expression of bcl\u20102 in B\u2010chronic lymphocytic leukemia cells.","volume":"79","author":"Schena M","year":"1992","journal-title":"Blood"},{"key":"e_1_2_10_145_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509107902"},{"key":"e_1_2_10_146_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01670.x"},{"key":"e_1_2_10_147_2","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood.V91.11.4273","article-title":"Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo\u20101\/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.","volume":"91","author":"Tinhofer I","year":"1998","journal-title":"Blood"}],"container-title":["Reviews in Clinical and Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-0734.2000.00004.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-0734.2000.00004.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1468-0734.2000.00004.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-0734.2000.00004.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:56:00Z","timestamp":1694404560000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-0734.2000.00004.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1046\/j.1468-0734.2000.00004.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-0734.2000.00004.x","archive":["Portico"],"relation":{},"ISSN":["1127-0020","1468-0734"],"issn-type":[{"value":"1127-0020","type":"print"},{"value":"1468-0734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}